Last updated: February 25, 2026
What is the Therapeutic Use of NDC 51079-0565?
NDC 51079-0565 refers to a specific drug formulation marketed under the National Drug Code system. According to FDA records, this NDC is associated with [Drug Name], which is classified for [indication e.g., oncology, infectious diseases, metabolic disorders, etc.]. The drug’s primary mechanism involves [brief mechanism description], and it has been approved since [approval date].
Market Size and Demand Dynamics
The total market size for drugs in this category is driven by [factors, e.g., patient prevalence, treatment guidelines, approval of new indications]. Currently, the estimated number of patients eligible for this treatment is [number], with annual growth rates at approximately [percentage] due to demographic shifts and evolving clinical practices.
Market Segments
| Segment |
Market Share |
Description |
| On-label use |
[X]% |
Approved indications for the drug |
| Off-label use |
[Y]% |
Unapproved but clinically accepted uses |
| Specialty pharmacies |
[Z]% |
Distribution channels |
By region, the U.S. accounts for approximately [percentage] of the global market, with Europe representing [percentage], driven by favorable reimbursement policies and comparable patient demographics.
Competitive Landscape
The drug competes mainly with [major competitor drugs, e.g., Drug A, Drug B, Drug C]. Market share distribution, based on recent sales figures, is as follows:
| Drug |
Market Share |
Approximate Revenue (USD millions) |
Description |
| NDC 51079-0565 |
[X]% |
[Y] |
This drug’s market share |
| Competitor A |
[A]% |
[B] |
Often used as substitute |
| Competitor B |
[C]% |
[D] |
Niche player |
Pricing for these competitors varies, with the average wholesale price (AWP) around $[price] per unit.
Pricing Trends and Projections
Current wholesale acquisition costs (WAC) for NDC 51079-0565 are approximately $[initial price] per [dose form, e.g., tablet, vial]. These prices reflect demand, manufacturing costs, regulatory environment, and reimbursement landscapes.
Historical Price Changes
| Year |
Average Price per Unit |
Notes |
| 2020 |
$[price] |
Launch year price |
| 2021 |
$[price] |
Minor increases (~X%) |
| 2022 |
$[price] |
Price stabilization |
Future Price Projections (Next 5 Years)
Forecasting models predict a compound annual growth rate (CAGR) of [percentage]% in wholesale prices, influenced by:
- Patent exclusivity status: Patent expiry expected in [year], risking price erosion.
- Introduction of generics or biosimilars: Entry anticipated by [year], possibly reducing prices by [percentage]% within [timeframe].
- Reimbursement policies: Tightening regulations could cap prices, limiting growth.
- Market demand: Growing patient population will support steady revenue.
Projected average price per unit over the next five years:
| Year |
Predicted Price (USD) |
Confidence Level |
| 2023 |
$[price] |
High |
| 2024 |
$[price] |
Moderate |
| 2025 |
$[price] |
Low |
| 2026 |
$[price] |
Very Low |
| 2027 |
$[price] |
Uncertain |
Revenue Projections
Assuming stable market share, a patient base of [number] patients, and current pricing, estimated revenue in 2023 is $[amount]. If generic competition materializes by [year], revenue could decline by up to [percentage]% within two years unless new indications or formulations support premium pricing.
Regulatory and Reimbursement Impact
Key factors include:
- Patent status: Patent expiry in [year] could open the market to generics, reducing prices.
- FDA decision timelines: Pending approvals for additional indications could expand market size.
- Insurance coverages: Reimbursement rates influence net pricing; policies favoring high-cost therapies may sustain price levels.
Key Takeaways
- NDC 51079-0565 is positioned within a growing, competitive market segment with an estimated global size of [dollars].
- Price stability hinges on patent protection, regulatory approvals, and market penetration.
- The drug faces competitive pressure from generic versions, with potential price erosion beginning as early as [year].
- Forecasted CAGR for wholesale prices is [percentage]% over the next five years.
- Revenue projections must incorporate evolving reimbursement landscapes and new market entrants.
FAQs
1. When is patent expiry for NDC 51079-0565?
Patent expiration is anticipated in [year], opening the market to generics.
2. What factors could cause price increases?
Regulatory approval for new indications and market exclusivity extensions could support higher prices.
3. How does the competitive landscape affect future pricing?
Entry of biosimilars or generics will exert downward pressure, typically reducing prices by [percentage]% within [timeframe].
4. What regions are most lucrative for sales?
The U.S. remains the largest market, accounting for approximately [percentage]% of global sales, followed by Europe and Asia.
5. How sensitive is the revenue to market share changes?
A [percentage]% decline in market share could decrease revenue by [amount]; thus, market share stability is critical.
References
- FDA. (2023). Drug product information. Retrieved from https://www.fda.gov
- IQVIA. (2023). Market analytics for specialty pharmaceuticals.
- U.S. Patent and Trademark Office. (2023). Patent expiry timelines.
- IMS Health. (2022). Global pharmaceutical market overview.
- Centers for Medicare & Medicaid Services. (2023). Reimbursement policies.
